Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases

Sophia Frentzas(Institute of Cancer Research), Ève Simoneau(Royal Victoria Regional Health Centre), Victoria L. Bridgeman(Institute of Cancer Research), Peter Vermeulen(Institute of Cancer Research), Shane Foo(Institute of Cancer Research), Eleftherios Kostaras(Institute of Cancer Research), Mark R. Nathan(Institute of Cancer Research), Andrew Wotherspoon(Royal Marsden Hospital), Zu‐Hua Gao(Royal Victoria Regional Health Centre), Yu Shi(Royal Victoria Regional Health Centre), Gert Van den Eynden(GZA Ziekenhuizen Campus Sint-Augustinus), Frances Daley(Breast Cancer Now), Clare Peckitt(Royal Marsden Hospital), Xianming Tan(University of North Carolina at Chapel Hill), Ayat Salman(Royal Victoria Regional Health Centre), Anthoula Lazaris(Royal Victoria Regional Health Centre), Patrycja Gazińska(Guy's Hospital), Tracy J. Berg(Institute of Cancer Research), Zakaria Eltahir(Royal Marsden Hospital), Laila Ritsma(Royal Netherlands Academy of Arts and Sciences), Jacco van Rheenen(Royal Netherlands Academy of Arts and Sciences), Alla Khashper(Royal Victoria Regional Health Centre), Gina Brown(Royal Marsden Hospital), Hanna Nyström(Umeå University), Malin Sund(Umeå University), Steven Van Laere(GZA Ziekenhuizen Campus Sint-Augustinus), Evelyne M. Loyer(The University of Texas MD Anderson Cancer Center), Luc Dirix(GZA Ziekenhuizen Campus Sint-Augustinus), David Cunningham(Royal Marsden Hospital), Peter Metrakos(Royal Victoria Regional Health Centre), Andrew R. Reynolds(Institute of Cancer Research)
Nature Medicine
October 17, 2016
Cited by 434

Abstract


Related Papers

No related papers found

Powered by citation graph analysis